Moderate to High-risk Noncardiac Surgery
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Edwards LifesciencesCA - Irvine
2 programsAcumen HPI Smart Alerts and Smart Trends SoftwareN/A1 trial
AcumenTM HPI Software FeatureN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Edwards LifesciencesAcumen HPI Smart Alerts and Smart Trends Software
Edwards LifesciencesAcumenTM HPI Software Feature
Clinical Trials (2)
Total enrollment: 703 patients across 2 trials
SMART TRENDS Study
Start: Jul 2023Est. completion: Oct 2025296 patients
N/ACompleted
Hypotension Prediction Index (HPI) SMART-BP Trial
Start: Nov 2021Est. completion: Dec 2022407 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.